Form 4: Illumina Director Philip Schiller Acquires 2,072 Shares

Director Philip W. Schiller acquired 2,072 restricted stock units of Illumina, Inc. as part of an equity grant.

Summary

• Director Philip W. Schiller was granted 2,072 restricted stock units (RSUs) of Illumina, Inc. common stock.
• The transaction occurred on May 21, 2026, at a valuation of $144.83 per share.
• Following this transaction, the director's total beneficial ownership stands at 22,220 shares.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a routine administrative filing regarding director compensation, which is neutral in terms of market impact.

Positives

• Alignment of director interests with shareholders through equity-based compensation.
• Increased direct ownership stake by a member of the board.

Negatives

• None identified.

Risks

• Vesting of the RSU award is contingent upon continued service as a director.

Future Outlook

The RSU award vests on the earlier of the one-year anniversary of the grant date or the date immediately preceding the next annual meeting of stockholders, subject to continued service.

Industry Context

StockSavvy.ai notes that director equity grants are standard corporate governance practices designed to incentivize long-term board commitment and align leadership with shareholder value creation in the biotechnology sector.

Comparison to Industry Standards

• The grant follows standard industry practices for non-employee director compensation packages in large-cap life sciences companies.

Stakeholder Impact

• Positive signal to shareholders regarding director commitment to the company's long-term performance.

Next Steps

• Vesting of the 2,072 restricted stock units on or before the 2027 annual meeting of stockholders.

Key Dates

Keywords

Illumina, ILMN, Insider Trading, Form 4, Director Compensation, Equity Grant